Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma

Clinical trial NCT02468557 · TERMINATED

Trial details

NCT number: NCT02468557
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Previously Untreated Pancreatic Ductal Adenocarcinoma Relapsed/Refractory Pancreatic Ductal Adenocarcinoma

Start date: 2015-07-30
Primary completion: 2016-04-27
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.